In NSCLC, MANA-specific CD8+ TILs show high PD-1 expression alongside other checkpoints (e.g., CTLA-4, TIGIT), correlating with incomplete cytolytic activation and resistance to ICIs [252]. The gene discussed is CTLA4; the disease is non-small cell lung carcinoma.